|
1
|
Laslett LJ, Alagona P Jr, Clark BA III,
Drozda JP Jr, Saldivar F, Wilson SR, Poe C and Hart M: The
worldwide environment of cardiovascular disease: Prevalence,
diagnosis, therapy, and policy issues: A report from the American
College of Cardiology. J Am Coll Cardiol. 60 25 Suppl:S1–S49. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nabel EG: Cardiovascular disease. N Engl J
Med. 349:60–72. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sáez P and Kuhl E: Computational modeling
of acute myocardial infarction. Comput Methods Biomech Biomed
Engin. 19:1107–1115. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Flynn A, Chen X, O'Connell E and O'Brien
T: A comparison of the efficacy of transplantation of bone
marrow-derived mesenchymal stem cells and unrestricted somatic stem
cells on outcome after acute myocardial infarction. Stem Cell Res
Ther. 3:362012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Michaels AD and Chatterjee K: Cardiology
patient pages. Angioplasty versus bypass surgery for coronary
artery disease. Circulation. 106:e187–e190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hsiao LC, Carr C, Chang KC, Lin SZ and
Clarke K: Stem cell-based therapy for ischemic heart disease. Cell
Transplant. 22:663–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carvalho JL, Braga VB, Melo MB, Campos AC,
Oliveira MS, Gomes DA, Ferreira AJ, Santos RA and Goes AM: Priming
mesenchymal stem cells boosts stem cell therapy to treat myocardial
infarction. J Cell Mol Med. 17:617–625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krishna KA, Krishna KS, Berrocal R, Rao KS
and Rao Sambasiva KR: Myocardial infarction and stem cells. J Pharm
Bioallied Sci. 3:182–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei X, Yang X, Han ZP, Qu FF, Shao L and
Shi YF: Mesenchymal stem cells: A new trend for cell therapy. Acta
Pharmacol Sin. 34:747–754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SH, Moon HH, Kim HA, Hwang KC, Lee M
and Choi D: Hypoxia-inducible vascular endothelial growth
factor-engineered mesenchymal stem cells prevent myocardial
ischemic injury. Mol Ther. 19:741–750. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reiser J, Zhang XY, Hemenway CS, Mondal D,
Pradhan L and La Russa VF: Potential of mesenchymal stem cells in
gene therapy approaches for inherited and acquired diseases. Expert
Opin Biol Ther. 5:1571–1584. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Santos JL, Pandita D, Rodrigues J, Pêgo
AP, Granja PL and Tomás H: Non-viral gene delivery to mesenchymal
stem cells: Methods, strategies and application in bone tissue
engineering and regeneration. Curr Gene Ther. 11:46–57. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nayerossadat N, Maedeh T and Ali PA: Viral
and nonviral delivery systems for gene delivery. Adv Biomed Res.
1:272012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yue J, Wu J, Liu D, Zhao X and Lu WW: BMP2
gene delivery to bone mesenchymal stem cell by chitosan-g-PEI
nonviral vector. Nanoscale Res Lett. 10:2032015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pang P, Wu C, Shen M, Gong F, Zhu K, Jiang
Z, Guan S, Shan H and Shuai X: An MRI-visible non-viral vector
bearing GD2 single chain antibody for targeted gene delivery to
human bone marrow mesenchymal stem cells. PLoS One. 8:e766122013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laron Z: Insulin-like growth factor 1
(IGF-1): A growth hormone. Mol Pathol. 54:311–316. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Davis ME, Hsieh PC, Takahashi T, Song Q,
Zhang S, Kamm RD, Grodzinsky AJ, Anversa P and Lee RT: Local
myocardial insulin-like growth factor 1 (IGF-1) delivery with
biotinylated peptide nanofibers improves cell therapy for
myocardial infarction. Proc Natl Acad Sci USA. 103:8155–8160. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delafontaine P, Song YH and Li Y:
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1
binding proteins in blood vessels. Arterioscler Thromb Vasc Biol.
24:435–444. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lisa M, Haleagrahara N and Chakravarthi S:
Insulin-like growth factor-1 (IGF-1) reduces ischemic changes and
increases circulating angiogenic factors in experimentally-induced
myocardial infarction in rats. Vasc Cell. 3:132011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo J, Zheng D, Li WF, Li HR, Zhang AD and
Li ZC: Insulin-like growth factor 1 treatment of MSCs attenuates
inflammation and cardiac dysfunction following MI. Inflammation.
37:2156–2163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schertzer JD and Lynch GS: Comparative
evaluation of IGF-I gene transfer and IGF-I protein administration
for enhancing skeletal muscle regeneration after injury. Gene Ther.
13:1657–1664. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boyle AJ, Schulman SP, Hare JM and Oettgen
P: Is stem cell therapy ready for patients? Stem cell therapy for
cardiac repair. ready for the next step. Circulation. 114:339–352.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Chen X, Wang WE and Zeng C: How to
improve the survival of transplanted mesenchymal stem cell in
ischemic heart? Stem Cells Int. 2016:96827572016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Terrovitis JV, Smith RR and Marbán E:
Assessment and optimization of cell engraftment after
transplantation into the heart. Circ Res. 106:479–494. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Basu S, Campbell HM, Dittel BN and Ray A:
Purification of specific cell population by fluorescence activated
cell sorting (FACS). J Vis Exp. 41:pii: 1546. 2010.
|
|
26
|
Kolossov E, Bostani T, Roell W, Breitbach
M, Pillekamp F, Nygren JM, Sasse P, Rubenchik O, Fries JW, Wenzel
D, et al: Engraftment of engineered ES cell-derived cardiomyocytes
but not BM cells restores contractile function to the infarcted
myocardium. J Exp Med. 203:2315–2327. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jacot JG, Kita-Matsuo H, Wei KA, Chen HS,
Omens JH, Mercola M and McCulloch AD: Cardiac myocyte force
development during differentiation and maturation. Ann N Y Acad
Sci. 1188:121–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim S, Kim GJ, Miyoshi H, Moon SH, Ahn SE,
Lee JH, Lee HJ, Cha KY and Chung HM: Efficiency of the elongation
factor-1alpha promoter in mammalian embryonic stem cells using
lentiviral gene delivery systems. Stem Cells Dev. 16:537–545. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang G, Gurtu V and Kain SR: An enhanced
green fluorescent protein allows sensitive detection of gene
transfer in mammalian cells. Biochem Biophys Res Commun.
227:707–711. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nam HY, Nam K, Lee M, Kim SW and Bull DA:
Dendrimer type bio-reducible polymer for efficient gene delivery. J
Control Release. 160:592–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Won YW, McGinn AN, Lee M, Nam K, Bull DA
and Kim SW: Post-translational regulation of a hypoxia-responsive
VEGF plasmid for the treatment of myocardial ischemia.
Biomaterials. 34:6229–6238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Khan RS, Martinez MD, Sy JC, Pendergrass
KD, Che PL, Brown ME, Cabigas EB, Dasari M, Murthy N and Davis ME:
Targeting extracellular DNA to deliver IGF-1 to the injured heart.
Sci Rep. 4:42572014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pi Y, Goldenthal MJ and Marín-García J:
Mitochondrial involvement in IGF-1 induced protection of
cardiomyocytes against hypoxia/reoxygenation injury. Mol Cell
Biochem. 301:181–189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bagno LL, Carvalho D, Mesquita F, Louzada
RA, Andrade B, Kasai-Brunswick TH, Lago VM, Suhet G, Cipitelli D,
Werneck-de-Castro JP and Campos-de-Carvalho AC: Sustained IGF-1
secretion by adipose-derived stem cells improves infarcted heart
function. Cell Transplant. 25:1609–1622. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Boucher M, Pesant S, Lei YH, Nanton N,
Most P, Eckhart AD, Koch WJ and Gao E: Simultaneous administration
of insulin-like growth factor-1 and darbepoetin alfa protects the
rat myocardium against myocardial infarction and enhances
angiogenesis. Clin Transl Sci. 1:13–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
